Yes I told him he was incorrectly listed as President of Radient on Bloomberg.
But I doubt he cares. Nobody with market savvy takes the RXPC page on Bloomberg seriously. RXPC doesn't come up in a ticker search on Bloomberg and when you do manage to find their RXPC page by first finding the German page, it shows the O/S as 1.35 billion:
In conclusion: An investor would have to be remarkably naïve to believe the Bloomberg information about Radient. Unfortunately, for those naïve few, the internet contains all kinds of misleading and false stock information.
I choose to believe SEC filings, which means I believe Radient is insolvent, RXPC shares are revoked, and the only Officers and Board Members are the four Australians. I also believe the lack of Schedule 13's proves there is no takeover. But, SEC filings are not for everyone -- they prove too confusing for some.
'Twas ever thus.
Incidentally, if you doubt the validity of MacLellan's email response, ask him yourself. I'm sure he will answer. I think he is eager to distance himself from Radient Pharmaceuticals. As for Mr. Charter responding -- unlikely, IMO.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.